Abstract
Rationale
Cognitive impairments are important determinants of functional outcome in psychosis, which are inadequately treated by antipsychotic medication. Modafinil is a wake-promoting drug that has been shown to improve attention, memory and executive function in the healthy population and in patients with schizophrenia.
Objectives
We aimed to establish modafinil’s role in the adjunctive treatment of cognitive impairments in the first episode of psychosis, a time when symptoms may be more malleable than at chronic stages of the disease.
Methods
Forty patients with a first episode of psychosis participated in a randomised, double-blind, placebo-controlled crossover design study assessing the effects of a single dose of 200 mg modafinil on measures of executive functioning, memory, learning, impulsivity and attention.
Results
Modafinil improved verbal working memory (d = 0.24, p = 0.04), spatial working memory errors (d = 0.30, p = 0.0004) and strategy use (d = 0.23, p = 0.03). It also reduced discrimination errors in a task testing impulsivity. Modafinil showed no effect on impulsivity measures, sustained attention, attentional set-shifting, learning or fluency.
Conclusions
Modafinil selectively enhances working memory in first episode psychosis patients, which could have downstream effects on patients’ social and occupational functioning.
Similar content being viewed by others
References
Addington J, Chaves A, Addington D (2006) Diagnostic stability over one year in first-episode psychosis. Schizophr Res 86(1–3):71–75
Aron AR, Fletcher PC, Bullmore ET, Sahakian BJ, Robbins TW (2003) Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat Neurosci 6(2):115–116
Beddington J, Cooper CL, Field J, Goswami U, Huppert FA, Jenkins R, Jones HS, Kirkwood TB, Sahakian BJ, Thomas SM (2008) The mental wealth of nations. Nature 455(7216):1057–1060
Beracochea D, Celerier A, Borde N, Valleau M, Peres M, Pierard C (2002) Improvement of learning processes following chronic systemic administration of modafinil in mice. Pharmacol Biochem Behav 73(3):723–728
Clark L, Robbins TW, Ersche KD, Sahakian BJ (2006) Reflection impulsivity in current and former substance users. Biol Psychiatry 60(5):515–522
Constantinidis C, Wang XJ (2004) A neural circuit basis for spatial working memory. Neuroscientist 10(6):553–565
Darwish M, Kirby M, Hellriegel ET (2009) Comparison of steady-state plasma concentrations of armodafinil and modafinil late in the day following morning administration: post hoc analysis of two randomized, double-blind, placebo-controlled, multiple-dose studies in healthy male subjects. Clin Drug Investig 29(9):601–612
de Saint Hilaire Z, Orosco M, Rouch C, Blanc G, Nicolaidis S (2001) Variations in extracellular monoamines in the prefrontal cortex and medial hypothalamus after modafinil administration: a microdialysis study in rats. NeuroReport 12(16):3533–3537
Doughty OJ, Done DJ (2009) Is semantic memory impaired in schizophrenia? A systematic review and meta-analysis of 91 studies. Cogn Neuropsychiatry 14(6):473–509
Enticott PG, Ogloff JR, Bradshaw JL (2008) Response inhibition and impulsivity in schizophrenia. Psychiatry Res 157(1–3):251–254
Ferraro L, Antonelli T, Tanganelli S, O’Connor WT, Perez de la Mora M, Mendez-Franco J, Rambert FA, Fuxe K (1999) The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade. Neuropsychopharmacology 20(4):346–356
Green MF (2006) Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J Clin Psychiatry 67(Suppl 9):3–8, discussion 36–42
Howell D (1997) Statistical methods for psychology. International Thomson Publishing, Belmont
Huddy VC, Aron AR, Harrison M, Barnes TR, Robbins TW, Joyce EM (2009) Impaired conscious and preserved unconscious inhibitory processing in recent onset schizophrenia. Psychol Med 39(6):907–916
Hunter MD, Ganesan V, Wilkinson ID, Spence SA (2006) Impact of modafinil on prefrontal executive function in schizophrenia. Am J Psychiatry 163(12):2184–2186
Joyce E, Hutton S, Mutsatsa S, Gibbins H, Webb E, Paul S, Robbins T, Barnes T (2002) Executive dysfunction in first-episode schizophrenia and relationship to duration of untreated psychosis: the West London Study. Br J Psychiatry Suppl 43:s38–s44
Keefe RS, Seidman LJ, Christensen BK, Hamer RM, Sharma T, Sitskoorn MM, Lewine RR, Yurgelun-Todd DA, Gur RC, Tohen M, Tollefson GD, Sanger TM, Lieberman JA (2004) Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol. Am J Psychiatry 161(6):985–995
Kehagia AA, Murray GK, Robbins TW (2010) Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation. Curr Opin Neurobiol 20(2):199–204
Leeson VC, Robbins TW, Franklin C, Harrison M, Harrison I, Ron MA, Barnes TR, Joyce EM (2009a) Dissociation of long-term verbal memory and fronto-executive impairment in first-episode psychosis. Psychol Med 39(11):1799–1808
Leeson VC, Robbins TW, Matheson E, Hutton SB, Ron MA, Barnes TR, Joyce EM (2009b) Discrimination learning, reversal, and set-shifting in first-episode schizophrenia: stability over six years and specific associations with medication type and disorganization syndrome. Biol Psychiatry 66(6):586–593
Marczinski CA, Kertesz A (2006) Category and letter fluency in semantic dementia, primary progressive aphasia, and Alzheimer’s disease. Brain Lang 97(3):258–265
McGorry PD, Edwards J, Mihalopoulos C, Harrigan SM, Jackson HJ (1996) EPPIC: an evolving system of early detection and optimal management. Schizophr Bull 22(2):305–326
McGorry PD, Nelson B, Amminger GP, Bechdolf A, Francey SM, Berger G, Riecher-Rossler A, Klosterkotter J, Ruhrmann S, Schultze-Lutter F, Nordentoft M, Hickie I, McGuire P, Berk M, Chen EY, Keshavan MS, Yung AR (2009) Intervention in individuals at ultra high risk for psychosis: a review and future directions. J Clin Psychiatry 70(9):1206–1212
Minzenberg MJ, Watrous AJ, Yoon JH, Ursu S, Carter CS (2008) Modafinil shifts human locus coeruleus to low-tonic, high-phasic activity during functional MRI. Science 322(5908):1700–1702
Minzenberg M, Watrous AJ, Yoon JH, Nunez del Prado J, Ursu S, Ragland JD, Carter CS (2009) Modafinil effects on prefrontal cortex during cognitive control in schizophrenia: a pharmaco-fMRI study. International Congress on Schizophrenia Research, San Diego
Owen AM, Downes JJ, Sahakian BJ, Polkey CE, Robbins TW (1990) Planning and spatial working memory following frontal lobe lesions in man. Neuropsychologia 28(10):1021–1034
Pantelis C, Wood SJ, Proffitt TM, Testa R, Mahony K, Brewer WJ, Buchanan JA, Velakoulis D, McGorry PD (2009) Attentional set-shifting ability in first-episode and established schizophrenia: relationship to working memory. Schizophr Res 112(1–3):104–113
Park SB, Coull JT, McShane RH, Young AH, Sahakian BJ, Robbins TW, Cowen PJ (1994) Tryptophan depletion in normal volunteers produces selective impairments in learning and memory. Neuropharmacology 33(3–4):575–588
Park I, Kim JJ, Seok JH, Chun JW, Son SJ, Park HJ, Lee JD (2007) The neural substrate of sustained attention to emotional stimuli and modafinil effect on attention in schizophrenia: a [15O] H2O PET study. International Congress of Schizophrenia Research, Colorado Springs, CO, USA, Schizophrenia Bulletin
Pierard C, Liscia P, Philippin JN, Mons N, Lafon T, Chauveau F, Van Beers P, Drouet I, Serra A, Jouanin JC, Beracochea D (2007) Modafinil restores memory performance and neural activity impaired by sleep deprivation in mice. Pharmacol Biochem Behav 88(1):55–63
Purdon SE, Jones BD, Stip E, Labelle A, Addington D, David SR, Breier A, Tollefson GD (2000) Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia. Arch Gen Psychiatry 57(3):249–258
Rasmusson DX, Bylsma FW, Brandt J (1995) Stability of performance on the Hopkins Verbal Learning Test. Arch Clin Neuropsychol 10(1):21–26
Remington G, Foussias G, Agid O (2010) Progress in defining optimal treatment outcome in schizophrenia. CNS Drugs 24(1):9–20
Robbins TW (2005) Chemistry of the mind: neurochemical modulation of prefrontal cortical function. J Comp Neurol 493(1):140–146
Robbins TW, Arnsten AF (2009) The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu Rev Neurosci 32:267–287
Robbins TW, Semple J, Kumar R, Truman MI, Shorter J, Ferraro A, Fox B, McKay G, Matthews K (1997) Effects of scopolamine on delayed-matching-to-sample and paired associates tests of visual memory and learning in human subjects: comparison with diazepam and implications for dementia. Psychopharmacology (Berl) 134(1):95–106
Roberts AC, Robbins TW, Everitt BJ (1988) The effects of intradimensional and extradimensional shifts on visual discrimination learning in humans and non-human primates. Q J Exp Psychol B 40(4):321–341
Sahakian BJ, Jones G, Levy R, Gray J, Warburton D (1989) The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. Br J Psychiatry 154:797–800
Sahakian BJ, Malloch G, Kennard C (2010) A UK strategy for mental health and wellbeing. Lancet 375(9729):1854–1855
Saletu B, Frey R, Krupka M, Anderer P, Grunberger J, Barbanoj MJ (1989) Differential effects of the new central adrenergic agonist modafinil and d-amphetamine on sleep and early morning behaviour in elderlies. Arzneimittelforschung 39(10):1268–1273
Saletu M, Anderer P, Semlitsch HV, Saletu-Zyhlarz GM, Mandl M, Zeitlhofer J, Saletu B (2007) Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy. Psychiatr Res Neuroimaging 154(1):69–84
Salokangas RK, McGlashan TH (2008) Early detection and intervention of psychosis. A review. Nord J Psychiatr 62(2):92–105
Smith D, Pernet A, Rosenthal JM, Bingham EM, Reid H, Macdonald IA, Amiel SA (2004) The effect of modafinil on counter-regulatory and cognitive responses to hypoglycaemia. Diabetologia 47(10):1704–1711
Swainson R, Hodges JR, Galton CJ, Semple J, Michael A, Dunn BD, Iddon JL, Robbins TW, Sahakian BJ (2001) Early detection and differential diagnosis of Alzheimer’s disease and depression with neuropsychological tasks. Dement Geriatr Cogn Disord 12(4):265–280
Thomas SP, Nandhra HS (2009) Early intervention in psychosis: a retrospective analysis of clinical and social factors influencing duration of untreated psychosis. Prim Care Companion J Clin Psychiatry 11(5):212–214
Turner DC, Robbins TW, Clark L, Aron AR, Dowson J, Sahakian BJ (2003) Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berl) 165(3):260–269
Turner DC, Clark L, Dowson J, Robbins TW, Sahakian BJ (2004a) Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder. Biol Psychiatry 55(10):1031–1040
Turner DC, Clark L, Pomarol-Clotet E, McKenna P, Robbins TW, Sahakian BJ (2004b) Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia. Neuropsychopharmacology 29(7):1363–1373
Ungerleider LG, Courtney SM, Haxby JV (1998) A neural system for human visual working memory. Proc Natl Acad Sci USA 95(3):883–890
Volkow ND, Fowler JS, Logan J, Alexoff D, Zhu W, Telang F, Wang GJ, Jayne M, Hooker JM, Wong C, Hubbard B, Carter P, Warner D, King P, Shea C, Xu Y, Muench L, Apelskog-Torres K (2009) Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. Jama 301(11):1148–1154
Wechsler D (1981) WAIS-R manual: Wechsler adult intelligence scale—revised. The Psychological Corporation, New York
Wesensten NJ, Belenky G, Thorne DR, Kautz MA, Balkin TJ (2004) Modafinil vs. caffeine: effects on fatigue during sleep deprivation. Aviat Space Environ Med 75(6):520–525
Wesensten NJ, Killgore WD, Balkin TJ (2005) Performance and alertness effects of caffeine, dextroamphetamine, and modafinil during sleep deprivation. J Sleep Res 14(3):255–266
Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell’Olio M, Francey SM, Cosgrave EM, Killackey E, Stanford C, Godfrey K, Buckby J (2005) Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Aust N Z J Psychiatry 39(11–12):964–971
Acknowledgements
We would like to thank the patients for their participation in the present study and our financial support from the Stanley Medical Research Institute and the Pinsent Darwin Fund of Cambridge University. Prof. Jones has received research support from the Wellcome Trust, NIHR and GSK. Prof. Sahakian has received consulting fees from Cambridge Cognition Ltd., GSK, Novartis, Shire, Lilly, and Boehringer-Ingelheim and has received honoraria from the Journal of Psychological Medicine, Grand Rounds in Psychiatry and the International Conference on Cognitive Dysfunction in Schizophrenia and Mood Disorders. Dr. Barnett is an employee of Cambridge Cognition Ltd and a co-inventor on patent PCT/GB2005/003279 (methods for assessing psychotic disorders) with Profs Jones and Sahakian. Dr. Soma and Dr. Scoriels reported no financial conflict of interests. The authors have full control of all primary data and agree to allow the journal to review this data if requested.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Scoriels, L., Barnett, J.H., Soma, P.K. et al. Effects of modafinil on cognitive functions in first episode psychosis. Psychopharmacology 220, 249–258 (2012). https://doi.org/10.1007/s00213-011-2472-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-011-2472-4